Tapewire

Nasdaq · USD

CME

CME GROUP INC.

Export transactions ↓
Tapewire entity
2909
SEC CIK
0001156375
Parsed reports
929

Last 12 months

Inside the activity.

7 purchase rows · 18 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202522
Jan 202600
Feb 202603
Mar 202624
Apr 202600
May 202603
Jun 202620
Jul 202600
Aug 202600
Sep 202613
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 03, 2017 Filed Jan 5, 2017 21:18 UTC
Tobin Jack JMD Chief Accounting Officer
SaleCommon Stock Class A 1,525 $116.16 $177,144.00
Disclosure

SEC source: 0001156375-17-000002 · edgardoc.xml · nonDerivative · entry 2

Tobin Jack J · CIK 0001638430 · MD Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,495

F1 · price: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

Read SEC document
January 03, 2017 Filed Jan 5, 2017 21:18 UTC
Tobin Jack JMD Chief Accounting Officer
Exercise / conversionCommon Stock Class A 1,525 $109.72 $167,323.00
Disclosure

SEC source: 0001156375-17-000002 · edgardoc.xml · nonDerivative · entry 1

Tobin Jack J · CIK 0001638430 · MD Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,020

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 29, 2016 Filed Jan 3, 2017 14:45 UTC
TAYLOR KIMBERLY SPres Clr & Post Trade Srvcs
SaleCommon Stock Class A 1,351 $115.88 $156,553.88
Disclosure

SEC source: 0001156375-17-000001 · edgardoc.xml · nonDerivative · entry 1

TAYLOR KIMBERLY S · CIK 0001271589 · Pres Clr & Post Trade Srvcs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,607

F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

Read SEC document
December 28, 2016 Filed Dec 29, 2016 22:53 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 12,280 $0.00 Strike: $54.37 $0.00
Disclosure

SEC source: 0001156375-16-000267 · edgardoc.xml · derivative · entry 6

Durkin Bryan T · CIK 0001341363 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock Class A · 12,280 shares

Expires 2021-09-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On September 15, 2015, these options vested with respect to 100% of the granted number of shares covered by the option.

Read SEC document
December 28, 2016 Filed Dec 29, 2016 22:53 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,606 $0.00 Strike: $54.30 $0.00
Disclosure

SEC source: 0001156375-16-000267 · edgardoc.xml · derivative · entry 5

Durkin Bryan T · CIK 0001341363 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock Class A · 2,606 shares

Expires 2020-09-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On September 15, 2014, these options vested with respect to 100% of the granted number of shares covered by the option.

Read SEC document
December 28, 2016 Filed Dec 29, 2016 22:53 UTC SaleCommon Stock Class A 2,606 $116.39 $303,317.29
Disclosure

SEC source: 0001156375-16-000267 · edgardoc.xml · nonDerivative · entry 4

Durkin Bryan T · CIK 0001341363 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,680

F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

F2 · price: On December 28, 2016, Mr. Durkin sold an aggregate of 14,886 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $115.87 to $115.97; $116.00 to $116.87; and $117.09 to $117.18. The Company maintains a record of the transactions and copies will be provided upon request.

Read SEC document
December 28, 2016 Filed Dec 29, 2016 22:53 UTC Exercise / conversionCommon Stock Class A 2,606 $54.30 $141,505.80
Disclosure

SEC source: 0001156375-16-000267 · edgardoc.xml · nonDerivative · entry 3

Durkin Bryan T · CIK 0001341363 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,286

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 28, 2016 Filed Dec 29, 2016 22:53 UTC SaleCommon Stock Class A 12,280 $116.39 $1,429,292.53
Disclosure

SEC source: 0001156375-16-000267 · edgardoc.xml · nonDerivative · entry 2

Durkin Bryan T · CIK 0001341363 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,680

F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

F2 · price: On December 28, 2016, Mr. Durkin sold an aggregate of 14,886 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $115.87 to $115.97; $116.00 to $116.87; and $117.09 to $117.18. The Company maintains a record of the transactions and copies will be provided upon request.

Read SEC document
December 28, 2016 Filed Dec 29, 2016 22:53 UTC Exercise / conversionCommon Stock Class A 12,280 $54.37 $667,663.60
Disclosure

SEC source: 0001156375-16-000267 · edgardoc.xml · nonDerivative · entry 1

Durkin Bryan T · CIK 0001341363 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,960

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 23, 2016 Filed Jan 9, 2017 21:49 UTC
Sammann DerekSr MD Gl Hd Comm &Options Prod
GiftCommon Stock Class A 675 $0.00 $0.00
Disclosure

SEC source: 0001156375-17-000004 · edgardoc.xml · nonDerivative · entry 2

Sammann Derek · CIK 0001475318 · Sr MD Gl Hd Comm &Options Prod

10b5-1 filing: Not disclosed

Ownership: Indirect · by Children

Disclosed balance after: 675

Read SEC document
December 23, 2016 Filed Jan 9, 2017 21:49 UTC
Sammann DerekSr MD Gl Hd Comm &Options Prod
GiftCommon Stock Class A 675 $0.00 $0.00
Disclosure

SEC source: 0001156375-17-000004 · edgardoc.xml · nonDerivative · entry 1

Sammann Derek · CIK 0001475318 · Sr MD Gl Hd Comm &Options Prod

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,226

F1 · shares: This transaction involved a gift of securities from the reporting person to his children, who share the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed as an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose.

Read SEC document
December 12, 2016 Filed Dec 13, 2016 23:23 UTC SaleCommon Stock Class A 382 $123.53 $47,188.46
Disclosure

SEC source: 0001156375-16-000264 · edgardoc.xml · nonDerivative · entry 1

Pankau Ronald A. · CIK 0001523463 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,000

Read SEC document
December 12, 2016 Filed Dec 13, 2016 22:13 UTC
Pietrowicz John W.Sr MD Chief Financial Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 4,625 $0.00 Strike: $110.54 $0.00
Disclosure

SEC source: 0001156375-16-000262 · edgardoc.xml · derivative · entry 3

Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock Class A · 4,625 shares

Expires 2017-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: On June 15, 2012, these options vested with respect to 100% of the granted number of shares covered by the option.

Read SEC document
December 12, 2016 Filed Dec 13, 2016 22:13 UTC
Pietrowicz John W.Sr MD Chief Financial Officer
SaleCommon Stock Class A 4,625 $123.30 $570,277.30
Disclosure

SEC source: 0001156375-16-000262 · edgardoc.xml · nonDerivative · entry 2

Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,169

F1 · price: On December 12, 2016, Mr. Pietrowicz sold an aggregate of 4,625 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $123.30 to $123.33. The Company maintains a record of the transactions and copies will be provided upon request.

Read SEC document
December 12, 2016 Filed Dec 13, 2016 22:13 UTC
Pietrowicz John W.Sr MD Chief Financial Officer
Exercise / conversionCommon Stock Class A 4,625 $110.54 $511,247.50
Disclosure

SEC source: 0001156375-16-000262 · edgardoc.xml · nonDerivative · entry 1

Pietrowicz John W. · CIK 0001485050 · Sr MD Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,794

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 09, 2016 Filed Dec 9, 2016 21:36 UTC SaleCommon Stock Class A 1,000 $122.45 $122,450.00
Disclosure

SEC source: 0001156375-16-000261 · edgardoc.xml · nonDerivative · entry 1

Suskind Dennis · CIK 0001361519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,099

F1 · price: On December 9, 2016, Mr. Suskind sold an aggregate of 1,000 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $122.42 to $122.49. The Company maintains a record of the transactions and copies will be provided upon request.

Read SEC document
December 09, 2016 Filed Dec 13, 2016 22:21 UTC OtherCommon Stock Class A 100 $0.00 $0.00
Disclosure

SEC source: 0001156375-16-000263 · edgardoc.xml · nonDerivative · entry 1

GEPSMAN MARTIN J · CIK 0001212813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,702

F1 · kind: Mr. Gepsman shared joint ownership of 495 shares of Class A common stock and of one share of Class B-4 common stock with two other members of the Chicago Mercantile Exchange Inc. On December 9, 2016, in consideration for receiving the partial ownership interest in the share of Class B-4 common stock from one of the other owners, Mr. Gepsman transferred to such individual 100 out of the 495 shares of Class A common stock that were jointly held.

Read SEC document
December 08, 2016 Filed Dec 9, 2016 21:36 UTC
DUFFY TERRENCE ADirector · Chairman & CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 27,550 $0.00 Strike: $110.54 $0.00
Disclosure

SEC source: 0001156375-16-000260 · edgardoc.xml · derivative · entry 3

DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock Class A · 27,550 shares

Expires 2017-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: On June 15, 2012, these options vested with respect to 100% of the granted number of shares covered by the option.

Read SEC document
December 08, 2016 Filed Dec 9, 2016 21:36 UTC
DUFFY TERRENCE ADirector · Chairman & CEO
SaleCommon Stock Class A 27,550 $120.44 $3,317,992.52
Disclosure

SEC source: 0001156375-16-000260 · edgardoc.xml · nonDerivative · entry 2

DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,364

F1 · price: On December 8, 2016, Mr. Duffy sold an aggregate of 27,550 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $120.14 to $120.76. The Company maintains a record of the transactions and copies will be provided upon request.

Read SEC document
December 08, 2016 Filed Dec 9, 2016 21:36 UTC
DUFFY TERRENCE ADirector · Chairman & CEO
Exercise / conversionCommon Stock Class A 27,550 $110.54 $3,045,377.00
Disclosure

SEC source: 0001156375-16-000260 · edgardoc.xml · nonDerivative · entry 1

DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,914

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 07, 2016 Filed Dec 8, 2016 22:18 UTC
Piell Hilda HarrisSr MD & Chief HR Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 3,275 $0.00 Strike: $110.54 $0.00
Disclosure

SEC source: 0001156375-16-000259 · edgardoc.xml · derivative · entry 9

Piell Hilda Harris · CIK 0001409789 · Sr MD & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock Class A · 3,275 shares

Expires 2017-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On June 15, 2012, these options vested with respect to 100% of the granted number of shares covered by the option.

Read SEC document
December 07, 2016 Filed Dec 8, 2016 22:18 UTC
Piell Hilda HarrisSr MD & Chief HR Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 2,200 $0.00 Strike: $109.72 $0.00
Disclosure

SEC source: 0001156375-16-000259 · edgardoc.xml · derivative · entry 8

Piell Hilda Harris · CIK 0001409789 · Sr MD & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock Class A · 2,200 shares

Expires 2017-09-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On September 14, 2012, these options vested with respect to 100% of the granted number of shares covered by the option.

Read SEC document
December 07, 2016 Filed Dec 8, 2016 22:18 UTC
Piell Hilda HarrisSr MD & Chief HR Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 375 $0.00 Strike: $106.58 $0.00
Disclosure

SEC source: 0001156375-16-000259 · edgardoc.xml · derivative · entry 7

Piell Hilda Harris · CIK 0001409789 · Sr MD & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock Class A · 375 shares

Expires 2017-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: On March 15, 2012, these options vested with respect to 100% of the granted number of shares covered by the option.

Read SEC document
December 07, 2016 Filed Dec 8, 2016 22:18 UTC
Piell Hilda HarrisSr MD & Chief HR Officer
SaleCommon Stock Class A 2,200 $120.00 $264,000.00
Disclosure

SEC source: 0001156375-16-000259 · edgardoc.xml · nonDerivative · entry 6

Piell Hilda Harris · CIK 0001409789 · Sr MD & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,125

F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

Read SEC document
December 07, 2016 Filed Dec 8, 2016 22:18 UTC
Piell Hilda HarrisSr MD & Chief HR Officer
Exercise / conversionCommon Stock Class A 2,200 $109.72 $241,384.00
Disclosure

SEC source: 0001156375-16-000259 · edgardoc.xml · nonDerivative · entry 5

Piell Hilda Harris · CIK 0001409789 · Sr MD & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,325

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 07, 2016 Filed Dec 8, 2016 22:18 UTC
Piell Hilda HarrisSr MD & Chief HR Officer
SaleCommon Stock Class A 3,275 $120.00 $393,000.00
Disclosure

SEC source: 0001156375-16-000259 · edgardoc.xml · nonDerivative · entry 4

Piell Hilda Harris · CIK 0001409789 · Sr MD & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,125

F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

Read SEC document
December 07, 2016 Filed Dec 8, 2016 22:18 UTC
Piell Hilda HarrisSr MD & Chief HR Officer
Exercise / conversionCommon Stock Class A 3,275 $110.54 $362,018.50
Disclosure

SEC source: 0001156375-16-000259 · edgardoc.xml · nonDerivative · entry 3

Piell Hilda Harris · CIK 0001409789 · Sr MD & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,400

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 07, 2016 Filed Dec 8, 2016 22:18 UTC
Piell Hilda HarrisSr MD & Chief HR Officer
SaleCommon Stock Class A 375 $120.00 $45,000.00
Disclosure

SEC source: 0001156375-16-000259 · edgardoc.xml · nonDerivative · entry 2

Piell Hilda Harris · CIK 0001409789 · Sr MD & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,125

F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

Read SEC document
December 07, 2016 Filed Dec 8, 2016 22:18 UTC
Piell Hilda HarrisSr MD & Chief HR Officer
Exercise / conversionCommon Stock Class A 375 $106.58 $39,967.50
Disclosure

SEC source: 0001156375-16-000259 · edgardoc.xml · nonDerivative · entry 1

Piell Hilda Harris · CIK 0001409789 · Sr MD & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 30, 2016 Filed Dec 1, 2016 19:47 UTC
TAYLOR KIMBERLY SSr MD Pres Gl Ops Tech & Risk
SaleCommon Stock Class A 2,300 $113.00 $259,900.00
Disclosure

SEC source: 0001156375-16-000258 · edgardoc.xml · nonDerivative · entry 1

TAYLOR KIMBERLY S · CIK 0001271589 · Sr MD Pres Gl Ops Tech & Risk

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,958

F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

Read SEC document
November 30, 2016 Filed Dec 1, 2016 19:46 UTC Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 15,000 $0.00 Strike: $54.30 $0.00
Disclosure

SEC source: 0001156375-16-000257 · edgardoc.xml · derivative · entry 3

Durkin Bryan T · CIK 0001341363 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,606

Underlying: Common Stock Class A · 15,000 shares

Expires 2020-09-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On September 15, 2014, these options vested with respect to 100% of the granted number of shares covered by the option.

Read SEC document
November 30, 2016 Filed Dec 1, 2016 19:46 UTC SaleCommon Stock Class A 15,000 $112.85 $1,692,735.00
Disclosure

SEC source: 0001156375-16-000257 · edgardoc.xml · nonDerivative · entry 2

Durkin Bryan T · CIK 0001341363 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,680

F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

F2 · price: On November 30, 2016, Mr. Durkin sold an aggregate of 15,000 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $112.67 to $112.98 and $113.00 to $113.29. The Company maintains a record of the transactions and copies will be provided upon request.

Read SEC document
November 30, 2016 Filed Dec 1, 2016 19:46 UTC Exercise / conversionCommon Stock Class A 15,000 $54.30 $814,500.00
Disclosure

SEC source: 0001156375-16-000257 · edgardoc.xml · nonDerivative · entry 1

Durkin Bryan T · CIK 0001341363 · President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,680

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 25, 2016 Filed Nov 28, 2016 22:27 UTC
DUFFY TERRENCE ADirector · Chairman & CEO
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 17,375 $0.00 Strike: $105.90 $0.00
Disclosure

SEC source: 0001156375-16-000256 · edgardoc.xml · derivative · entry 3

DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock Class A · 17,375 shares

Expires 2016-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: As of December 15, 2011, this option vested with respect to 100% of the granted number of shares covered by the option.

Read SEC document
November 25, 2016 Filed Nov 28, 2016 22:27 UTC
DUFFY TERRENCE ADirector · Chairman & CEO
SaleCommon Stock Class A 17,375 $112.58 $1,956,077.50
Disclosure

SEC source: 0001156375-16-000256 · edgardoc.xml · nonDerivative · entry 2

DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,364

F1 · price: On November 25, 2016, Mr. Duffy sold an aggregate of 17,375 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $112.55 to $112.61. The Company maintains a record of the transactions and copies will be provided upon request.

Read SEC document
November 25, 2016 Filed Nov 28, 2016 22:27 UTC
DUFFY TERRENCE ADirector · Chairman & CEO
Exercise / conversionCommon Stock Class A 17,375 $105.90 $1,840,012.50
Disclosure

SEC source: 0001156375-16-000256 · edgardoc.xml · nonDerivative · entry 1

DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,739

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 02, 2016 Filed Nov 3, 2016 17:13 UTC SaleCommon Stock Class A 400 $100.53 $40,212.00
Disclosure

SEC source: 0001156375-16-000252 · edgardoc.xml · nonDerivative · entry 2

Suskind Dennis · CIK 0001361519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,099

Read SEC document
November 02, 2016 Filed Nov 3, 2016 17:13 UTC SaleCommon Stock Class A 1,600 $100.52 $160,832.00
Disclosure

SEC source: 0001156375-16-000252 · edgardoc.xml · nonDerivative · entry 1

Suskind Dennis · CIK 0001361519 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,499

Read SEC document
October 31, 2016 Filed Nov 1, 2016 19:43 UTC
TAYLOR KIMBERLY SSr MD Pres Gl Ops Tech & Risk
SaleCommon Stock Class A 2,300 $100.21 $230,483.00
Disclosure

SEC source: 0001156375-16-000251 · edgardoc.xml · nonDerivative · entry 1

TAYLOR KIMBERLY S · CIK 0001271589 · Sr MD Pres Gl Ops Tech & Risk

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,258

F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

Read SEC document
October 31, 2016 Filed Nov 1, 2016 19:43 UTC
Durkin Bryan TSr MD Chief Commercial Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 10,226 $0.00 Strike: $56.87 $0.00
Disclosure

SEC source: 0001156375-16-000250 · edgardoc.xml · derivative · entry 6

Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock Class A · 10,226 shares

Expires 2019-09-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: On September 15, 2013, these options vested with respect to 100% of the granted number of shares covered by the option.

Read SEC document
October 31, 2016 Filed Nov 1, 2016 19:43 UTC
Durkin Bryan TSr MD Chief Commercial Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 4,774 $0.00 Strike: $54.30 $0.00
Disclosure

SEC source: 0001156375-16-000250 · edgardoc.xml · derivative · entry 5

Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,606

Underlying: Common Stock Class A · 4,774 shares

Expires 2020-09-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: On September 15, 2014, these options vested with respect to 100% of the granted number of shares covered by the option.

Read SEC document
October 31, 2016 Filed Nov 1, 2016 19:43 UTC
Durkin Bryan TSr MD Chief Commercial Officer
SaleCommon Stock Class A 10,226 $100.00 $1,022,557.05
Disclosure

SEC source: 0001156375-16-000250 · edgardoc.xml · nonDerivative · entry 4

Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,680

F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

F2 · price: On October 31, 2016, Mr. Durkin sold an aggregate of 15,000 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $99.59 to $99.99 and $100.00 to $100.25. The Company maintains a record of the transactions and copies will be provided upon request.

Read SEC document
October 31, 2016 Filed Nov 1, 2016 19:43 UTC
Durkin Bryan TSr MD Chief Commercial Officer
Exercise / conversionCommon Stock Class A 10,226 $56.87 $581,552.62
Disclosure

SEC source: 0001156375-16-000250 · edgardoc.xml · nonDerivative · entry 3

Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,906

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 31, 2016 Filed Nov 1, 2016 19:43 UTC
Durkin Bryan TSr MD Chief Commercial Officer
SaleCommon Stock Class A 4,774 $100.00 $477,379.95
Disclosure

SEC source: 0001156375-16-000250 · edgardoc.xml · nonDerivative · entry 2

Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,680

F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

F2 · price: On October 31, 2016, Mr. Durkin sold an aggregate of 15,000 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $99.59 to $99.99 and $100.00 to $100.25. The Company maintains a record of the transactions and copies will be provided upon request.

Read SEC document
October 31, 2016 Filed Nov 1, 2016 19:43 UTC
Durkin Bryan TSr MD Chief Commercial Officer
Exercise / conversionCommon Stock Class A 4,774 $54.30 $259,228.20
Disclosure

SEC source: 0001156375-16-000250 · edgardoc.xml · nonDerivative · entry 1

Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,454

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 03, 2016 Filed Oct 4, 2016 19:10 UTC
Tobin Jack JMD Chief Accounting Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 3,750 $0.00 Strike: $80.78 $0.00
Disclosure

SEC source: 0001156375-16-000244 · edgardoc.xml · derivative · entry 3

Tobin Jack J · CIK 0001638430 · MD Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock Class A · 3,750 shares

Expires 2017-01-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: As of 7/12/2007, this option vested with respect to 100% of the granted number of shares covered by the option.

Read SEC document
October 03, 2016 Filed Oct 4, 2016 19:10 UTC
Tobin Jack JMD Chief Accounting Officer
SaleCommon Stock Class A 3,750 $104.09 $390,337.50
Disclosure

SEC source: 0001156375-16-000244 · edgardoc.xml · nonDerivative · entry 2

Tobin Jack J · CIK 0001638430 · MD Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,495

F1 · price: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

Read SEC document
October 03, 2016 Filed Oct 4, 2016 19:10 UTC
Tobin Jack JMD Chief Accounting Officer
Exercise / conversionCommon Stock Class A 3,750 $80.78 $302,925.00
Disclosure

SEC source: 0001156375-16-000244 · edgardoc.xml · nonDerivative · entry 1

Tobin Jack J · CIK 0001638430 · MD Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,245

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 29, 2016 Filed Sep 30, 2016 17:06 UTC
TAYLOR KIMBERLY SSr MD Pres Gl Ops Tech & Risk
SaleCommon Stock Class A 2,300 $106.01 $243,823.00
Disclosure

SEC source: 0001156375-16-000243 · edgardoc.xml · nonDerivative · entry 1

TAYLOR KIMBERLY S · CIK 0001271589 · Sr MD Pres Gl Ops Tech & Risk

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,558

F1 · shares: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

Read SEC document
September 28, 2016 Filed Sep 30, 2016 17:06 UTC
Durkin Bryan TSr MD Chief Commercial Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 11,600 $0.00 Strike: $83.88 $0.00
Disclosure

SEC source: 0001156375-16-000242 · edgardoc.xml · derivative · entry 7

Durkin Bryan T · CIK 0001341363 · Sr MD Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock Class A · 11,600 shares

Expires 2018-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: These options were granted on June 16, 2008. They vest over a five-year period, with 20% vesting one year after the grant date and 20% vesting on that same date in each of the following three years, subject to acceleration or termination in certain circumstances.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.